Robecosam AG boosted its holdings in Danaher Co. (NYSE:DHR) by 29.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 407,405 shares of the conglomerate’s stock after purchasing an additional 91,965 shares during the quarter. Danaher comprises 2.3% of Robecosam AG’s investment portfolio, making the stock its 9th largest holding. Robecosam AG’s holdings in Danaher were worth $62,268,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. JJJ Advisors Inc. purchased a new position in Danaher during the 4th quarter worth $26,000. Cedar Mountain Advisors LLC purchased a new position in Danaher during the 4th quarter worth $28,000. Tobias Financial Advisors Inc. purchased a new position in Danaher during the 4th quarter worth $30,000. Liberty Wealth Management LLC raised its position in Danaher by 852.4% during the 4th quarter. Liberty Wealth Management LLC now owns 200 shares of the conglomerate’s stock worth $31,000 after buying an additional 179 shares during the last quarter. Finally, Savior LLC purchased a new position in Danaher during the 4th quarter worth $32,000. Hedge funds and other institutional investors own 79.72% of the company’s stock.
A number of brokerages have commented on DHR. Royal Bank of Canada downgraded shares of Danaher from an “outperform” rating to a “sector perform” rating in a research report on Thursday. JPMorgan Chase & Co. upped their price objective on shares of Danaher from $155.00 to $175.00 in a research report on Thursday, December 19th. Cowen restated a “buy” rating and set a $170.00 price objective on shares of Danaher in a research report on Monday, February 3rd. UBS Group upped their price objective on shares of Danaher from $165.00 to $176.00 and gave the stock a “neutral” rating in a research report on Friday, January 10th. Finally, Bank of America upped their price objective on shares of Danaher from $165.00 to $188.00 and gave the stock a “buy” rating in a research report on Friday, January 31st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $166.41.
Shares of NYSE:DHR traded up $9.34 on Thursday, reaching $138.66. 5,268,591 shares of the company were exchanged, compared to its average volume of 3,348,842. The company has a current ratio of 5.19, a quick ratio of 4.86 and a debt-to-equity ratio of 0.75. Danaher Co. has a 1-year low of $119.60 and a 1-year high of $169.19. The firm has a market cap of $89.92 billion, a price-to-earnings ratio of 34.24, a price-to-earnings-growth ratio of 2.14 and a beta of 0.96. The company has a 50-day moving average of $149.39 and a 200-day moving average of $147.49.
Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, January 30th. The conglomerate reported $1.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.25 by $0.03. Danaher had a net margin of 15.09% and a return on equity of 11.50%. The business had revenue of $4.87 billion for the quarter, compared to analysts’ expectations of $4.80 billion. During the same period in the prior year, the company posted $1.28 EPS. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. As a group, analysts forecast that Danaher Co. will post 5.38 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a dividend of $0.18 per share. The ex-dividend date is Thursday, March 26th. This is a boost from Danaher’s previous quarterly dividend of $0.17. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.52%. Danaher’s dividend payout ratio is 15.38%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
See Also: What is a trade deficit?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.